HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R298Q mutation of p63 gene in autosomal dominant ectodermal dysplasia associated with arrhythmogenic right ventricular cardiomyopathy.

Abstract
Mutations in the p63 gene have been identified in five types of syndromic ectodermal dysplasias (EDs) with overlapping phenotypes: Ectrodactyly-Ectodermal dysplasia-Clefting (EEC syndrome, MIM 604292), Ankyloblepharon-Ectodermal dysplasia-Clefting (AEC syndrome, MIM 106260) [3], Acro-Dermato-Ungueal-Lacrimal-Tooth (ADULT syndrome, MIM 103285), Rapp-Hodgkin (RHS syndrome, MIM 129400) and Limb-Mammary (LMS syndrome, MIM 603543) [2]. In all those conditions congenital heart defects have been only occasionally found and to date, arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) has never been observed in patients affected by p63-related ectodermal dysplasia [9]. Here we describe for the first time this association.
AuthorsMariella Valenzise, Teresa Arrigo, Francesco De Luca, Agata Privitera, Alessandro Frigiola, Adriana Carando, Emanuela Garelli, Margherita Silengo
JournalEuropean journal of medical genetics (Eur J Med Genet) Vol. 51 Issue 5 Pg. 497-500 ( 2008) ISSN: 1769-7212 [Print] Netherlands
PMID18603493 (Publication Type: Case Reports, Letter)
Chemical References
  • TP63 protein, human
  • Trans-Activators
  • Transcription Factors
  • Tumor Suppressor Proteins
Topics
  • Adolescent
  • Arrhythmogenic Right Ventricular Dysplasia (complications, genetics)
  • DNA Mutational Analysis
  • Ectodermal Dysplasia (complications, genetics)
  • Genes, Dominant
  • Humans
  • Male
  • Mutation
  • Phenotype
  • Trans-Activators (genetics)
  • Transcription Factors
  • Tumor Suppressor Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: